Stock Comparison
INCY vs REGN
Incyte Corporation and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$24.23B
$80.55B
P/E (TTM)
15.2
19.4
Forward P/E
38.4
17.1
Price/Sales
4.2
5.2
Price/Book
3.8
2.5
EV/EBITDA
9.5
13.1
Dividend Yield
—
0.45%
Profitability
Net Margin
26.71%
29.65%
Operating Margin
27.05%
24.32%
Return on Equity
30.70%
14.00%
Return on Assets
16.80%
6.53%
Growth (YoY)
Revenue Growth
37.70%
16.70%
Earnings Growth
37.70%
-4.50%
Price & Risk
Beta
0.8
0.2
52-Week High
$129.93
$810.12
52-Week Low
$81.66
$553.38
Analyst Target
$124.96
$833.54
Compare INCY and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.